A Study to Test How Well Patients With Plaque Psoriasis Tolerate BI 730357 Over a Longer Period and How Effective it is

PHASE2TerminatedINTERVENTIONAL
Enrollment

165

Participants

Timeline

Start Date

March 18, 2019

Primary Completion Date

June 22, 2021

Study Completion Date

July 27, 2021

Conditions
Psoriasis
Interventions
DRUG

BI 730357

Film-coated tablet

DRUG

Placebo to match BI 730357

Film-coated tablet

Trial Locations (30)

10003

Icahn School of Medicine at Mount Sinai, New York

10117

Charité - Universitätsmedizin Berlin, Berlin

20537

TFS Trial Form Support GmbH, Hamburg

23502

Virginia Clinical Research, Inc., Norfolk

23538

Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Lübeck

29407

Clinical Research Center of the Carolinas, Charleston

30022

Hamilton Research, Alpharetta

30328

Advanced Medical Research PC, Sandy Springs

35205

Total Skin and Beauty Dermatology Center, PC, Birmingham

46250

Dawes Fretzin Clinical Research Group, LLC, Indianapolis

48149

Universitätsklinikum Münster, Münster

57702

Health Concepts, Rapid City

60596

Universitätsklinikum Frankfurt, Frankfurt am Main

75246

Menter Dermatology Research Institute, Dallas

77004

Center for Clinical Studies, Houston

77598

Center for Clinical Studies, Webster

90045

Dermatology Research Associates, Los Angeles

92701

Southern California Dermatology Inc., Santa Ana

08520

The Psoriasis Treatment Center of Central New Jersey, East Windsor

02919

Clinical Partners, LLC, Johnston

V3R 6A7

Dr Chih-ho Hong Medical Inc, Surrey

V3V 0C6

Enverus Medical Research, Surrey

E3B 1G9

Dr. Irina Turchin PC Inc., Fredericton

N6A 3H7

The Guenther Dermatology Research Centre, London

L5H 1G9

DermEdge Research Inc., Mississauga

P1B 3Z7

North Bay Dermatology Centre, North Bay

L6J 7W5

The Centre for Clinical Trials, Oakville

K9J 5K2

SKiN Centre for Dermatology, Peterborough

N2J 1C4

K. Papp Clinical Research Inc., Waterloo

N8W 1E6

XLR8 Medical Research Inc., Windsor

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT03835481 - A Study to Test How Well Patients With Plaque Psoriasis Tolerate BI 730357 Over a Longer Period and How Effective it is | Biotech Hunter | Biotech Hunter